Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Hanmi Pharmaceutical Company Limited"
Count: 181
Selected: 0
| NCT ID | Title |
|---|
| NCT05711381 | Phase 1 PK Study to Assess Safety, PK, Tolerability of HM15912 in Subjects With Renal Impairment and Normal Renal Function | ||
| NCT04775706 | Phase 2 Study to Assess the Safety, PK, and PD in SBS-IF Subjects | ||
| NCT05656092 | A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer | ||
| NCT03089112 | Pharmacokinetic Drug Interactions Between HGP1607 and HGP1501 | ||
| NCT04325620 | Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease | ||
| NCT04204629 | Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects | ||
| NCT05598151 | Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors | ||
| NCT04732416 | HM15136 Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI) | ||
| NCT05555238 | An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With Dyslipidemia | ||
| NCT05548543 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions | ||
| NCT05548387 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers | ||
| NCT03666351 | Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease | ||
| NCT04505436 | Study to Evaluate Efficacy, Safety and Tolerability of HM15211 in Subjects | ||
| NCT05487560 | An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal Bleeding | ||
| NCT05481307 | A Study to Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between RLD2202 and RLD2203 | ||
| NCT05450601 | A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients | ||
| NCT04946903 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008 | ||
| NCT05462535 | An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet | ||
| NCT05024721 | Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis | ||
| NCT04959305 | A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension | ||
| NCT04762407 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903 | ||
| NCT03897868 | A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension | ||
| NCT03826641 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects | ||
| NCT05450575 | An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet | ||
| NCT05422677 | An Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia | ||
| NCT05407220 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Male Volunteers. | ||
| NCT05362110 | A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension | ||
| NCT04768686 | FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer | ||
| NCT03284502 | HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors | ||
| NCT04032782 | A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136 in Healthy Subjects | ||
| NCT05199129 | Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients | ||
| NCT02418689 | Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens | ||
| NCT03353350 | Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise | ||
| NCT05191563 | A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects. | ||
| NCT05155995 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers | ||
| NCT04654702 | Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap. | ||
| NCT03744182 | A Study of Multiple Doses of HM15211 in Obese Subjects With NAFLD | ||
| NCT04975711 | Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers | ||
| NCT04967014 | Study to Evaluate the Safety and Pharmacodynamic/Pharmacokinetic Characteristics of HIP2101 in Healthy Volunteers | ||
| NCT04830449 | Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients | ||
| NCT04167553 | Study for Multiple Doses of HM15136 in Obese or Overweight Subjects With Comorbidities | ||
| NCT04829149 | Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea | ||
| NCT04764201 | The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers | ||
| NCT03332836 | Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus | ||
| NCT04820907 | Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients | ||
| NCT04788290 | An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol | ||
| NCT04652349 | Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia | ||
| NCT02485652 | Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung | ||
| NCT04080726 | Efficacy and Safety of HIP1601 Capsule | ||
| NCT04074551 | A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia |
